Neural tube defects in the Czech Republic during 1961-1999: Incidences, prenatal diagnosis and prevalences according to maternal age

Journal of Obstetrics and Gynaecology

Volumn 22, Issue 5, 2002, Pages 501-507

  Sipek A ^a   Horacek J ^b   Gregor, V ^b   Rychtarikova J ^c   Dzurova D ^c   Masatova D ^d  

^a INSTITUTE FOR THE CARE OF MOTHER AND CHILD   (Czech Republic)

^b Postgradual Medical Institute   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d Institute of Health Information and Statistics of the Czech Republic   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANENCEPHALUS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CZECH REPUBLIC; ENCEPHALOCELE; EPIDEMIOLOGICAL DATA; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL AGE; NEURAL TUBE DEFECT; NEWBORN; POPULATION RESEARCH; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SPINA BIFIDA; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; COHORT STUDIES; CZECH REPUBLIC; FEMALE; FETAL DISEASES; HUMANS; INCIDENCE; MATERNAL AGE; MIDDLE AGED; NEURAL TUBE DEFECTS; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 0036752605     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/0144361021000003636     Document Type: Article

References (31)

1. Anonymous (1983) Vitamin supplementation and neural tube defects. Lancet, II, 39-40.
2. Borman G.B., Smith A.H. and Howard J.K. (1986) Risk factors in the prevalence of anencephalus and spina bifida in New Zealand. Teratology, 33, 221-230.
3. Cocchi G., Morini M.S., Lubelli A., Garani G.P., Calzolari E. and Magnani C. (1995) Epidemiology and surveillance of neural tube defects. Acta Paediatrica Latina., 48, 65-74.
4. Cornel M.C. for the EUROCAT Working Group (1994) Variation in prenatal cytogenetic diagnosis: policies in thirteen European countries, 1989-1991. Prenatal Diagnosis, 14, 337-344.
5. Czeizel A.E. (1995) Folic acid in the prevention of neural tube defects. Journal of Paediatric Gastroenterology and Nutrition, 20, 4-16.
6. Czeizel A.E. and Dudas I. (1992) Prevention of first occurrence of neural tube defects by periconceptional vitamin supplementation. New England Journal of Medicine, 327, 1832-1835.
7. Czeizel A.E. (1994) Periconceptional multivitamin supplementation in prevention of congenital abnormalities. Maternal and Child Health, 19, 381-384.
8. Czeizel A. and Karig G. (1985) Analysis of the changing birth prevalence of neural tube defects in Hungary. Acta Morphologica Hungarica, 33, 89-99.
9. De Vigan, C., Raoult, B., Vodovar, V. and Goujard, J. (1996) Prevention of anencephaly and spina bifida with folic acid: situation in the Parisian area. Bulletin Epidemiologique Hebdomadaire, 15, 69-71.
10. Dudin A. (1997) Neural tube defects among Palestinians: a hospital-based study. Annals of Tropical Paediatrics, 17, 217-222.
11. Elwood J.M., Raman S. and Mosseau G. (1978) Reproductive history in the mothers of anencephalics. Journal of Chronic Disease, 31, 473-481.
12. EUROCAT (1995) Surveillance of congenital anomalies in Europe 1980-1992. European registration of congenital anomalies, Part I, p. 38, Brussels, Institute of Hygiene and Epidemiology.
13. Harris R. (1988) Vitamins and neural tube defects. British Medical Journal, 296, 80-81.
14. Holmes L.B. (1988) Does taking vitamins at the time of conception prevent neural tube defects? Journal of the American Medical Association, 260, 3181.
15. ICBDMS (1991) Congenital malformations worldwide, pp. 41-58. Oxford, Elsevier.
16. ICBDMS (1996) Annual Report 1994, p 52. Rome, International Clearinghouse for Birth Defects Monitoring Systems.
17. Janerich D.T. (1972) Anencephaly and maternal age. American Journal of Epidemiology, 95, 319-324.
18. Kallen K. (1998) Maternal smoking, body mass index and neural tube defects. American Journal of Epidemiology, 147, 1103-1111.
19. Kučera J. (1979) Decrease of frequency of anencephaly in the Czech Republic in 1961-1975 [in Czech]. Československá. Pediatric, 34, 495-497.
20. Kulkarni, M.L., Mathew, M.A., Reddy, V. (1989) The range of neural tube defects in southern India. Archives of Disease in Childhood, 64, 201-204.
21. Lemire R.J., Beckwith J.B. and Warkany J. (1978) Anencephaly, 271 pp. New York, Raven Press.
22. Lian Z.H., Yang H.Y. and Li Z. (1987) Neural tube defects in Bejing-Tianjin area of China. Urban-rural distribution and some other epidemiological characteristics. Journal of Epidemiology and Community Health, 41, 259-262.
23. Mills J.L., Rhoads, G.G., Simpson J.L., Cunningham G.C., Conley M.R., Lassman R.M., Walden M.E., Depp R.O. and Hoffman H.J. (1989) The absence of a relation between the periconceptional use of vitamins and neural tube defects. New England Journal of Medicine, 321, 430-435.
24. Nevin N.C., Johnston W.P. and Merrett J.D. (1981) Influence of social class on the risk of recurrence of anencephalus and spina bifida. Developmental Medicine and Child Neurology, 23, 155-159.
25. Persaud T.V.N. and Persaud M.P. (1982) Central nervous system and craniofacial malformations. In: Advances in the study of birth defects, edited by Persaud T.V.N., volume 7, pp. 1-74. New York, Alan R. Liss.
26. Rhoads G.G. and Mills J.L. (1984) The role of the case-control study in evaluating health intervention. Vitamin supplementation and neural tube defects. American Journal of Epidemiology, 120, 803-808.
27. Shaw G.M., Velie E.M. and Wasserman C.R. (1997) Risk for neural tube affected pregnancies among women of Mexican descent and white women in California. American Journal of Public Health, 87, 1467-1471.
28. Shaw G.M., Todoroff K., Velie E.M. and Lammer E.J. (1998) Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology, 57, 1-7.
29. Stoll C., Alembik Y., Dott B., Roth M.P. and Stoll C. (1995) Prevalence of neural tube defects in northeastern France from 1979 to 1992. Annales de Génétique, 38, 49-53.
30. Šipek A., Gregor V. and Chudobová, M. (2000) Congenital malformations occurrence and prenatal diagnosis efficiency in the Czech Republic in 1998 [in Czech]. Československá. Pediatric, 55, 518-524.
31. Wenstrom K.D., Johanning G.L., Owen J., Johnston K.E., Acton S. and Tamura T. (2000) Role of amniotic fluid homocysteine level and of fetal 5, 10-methylenetetrahydrofolate reductase genotype in the etiology of neural tube defects. American Journal of Medical Genetics, 90, 12-16.